Crossmark

Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer

Crossref DOI link: https://doi.org/10.1007/s00595-020-02011-9

Published Online: 2020-05-26

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takahashi, Ryo

Nunobe, Souya

Osumi, Hiroki

Takahari, Daisuke

Yamamoto, Noriko

Ida, Satoshi

Kumagai, Koshi

Ohashi, Manabu

Sano, Takeshi

Hiki, Naoki
License Information

Text and Data Mining valid from 2020-05-26

Version of Record valid from 2020-05-26
More Information

Article History

Received: 28 January 2020

Accepted: 17 March 2020

First Online: 26 May 2020

Compliance with ethical standards

:

: We have no conflicts of interest to declare.

: The Institutional Review Boards approved this study (2018–1052).

Document is current

Any future updates will be listed below